Skip to main content
. 2019 Dec 4;69(8):1492–1501. doi: 10.1136/gutjnl-2019-318934

Figure 2.

Figure 2

Kaplan-Meier plots of median (A) progression-free survival, (B) TTUP and (C) TTP in the TACE plus sorafenib and TACE alone groups. TACE, transarterial chemoembolisation; TTP, time to progression; TTUP, time to untreatable (unTACEable) progression.